Furthermore, serum FGF21 levels were strikingly higher in patients with subclinical atherosclerosis compared to patients without subclinical atherosclerosis [261.3 (135.1–396.4) versus 144.9 (95.9–223.0) ng/L, P < 0.001]. This evidence concerns the gene FGF21 and atherosclerosis.